Respiratory drug manufacturers get their day in court
NAPA, Calif. - Drug makers Dey Laboratories and Sepracor face off in court Dec. 12. Dey sued Sepracor in April over the development of Brovana, which Dey said infringes on its Performist Inhalation Solution. Performist received Food and Drug Administration approval in May, while Sepracor's Brovana was approved last October. Both drugs are long-acting beta 2 agonists taken twice daily for COPD and are expected to go head-to-head in the rocky nebulizer medication market (see HME News, July 2007).